Wells Fargo Maintains Overweight on Acuity Brands, Lowers Price Target to $181
Wells Fargo analyst Joe O'Dea maintains Acuity Brands (NYSE:AYI) with a Overweight and lowers the price target from $200 to $181.
Baird Maintains Outperform on Acuity Brands, Lowers Price Target to $188
Baird analyst Timothy Wojs maintains Acuity Brands (NYSE:AYI) with a Outperform and lowers the price target from $210 to $188.
Acuity Brands Earnings Perspective: Return On Invested Capital
Pulled from Benzinga Pro data, Acuity Brands (NYSE:AYI) posted Q2 earnings of $75.30 million, an increase from Q1 of 14.04%. Sales dropped to $909.10 million, a 1.84% decrease between quarters.
Wells Fargo Maintains Overweight on Acuity Brands, Lowers Price Target to $200
Wells Fargo analyst Joe O'Dea maintains Acuity Brands (NYSE:AYI) with a Overweight and lowers the price target from $237 to $200.
51 Biggest Movers From Yesterday
Gainers
Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.
Earnings Scheduled For April 5, 2022
Companies Reporting Before The Bell
• Acuity Brands (NYSE:AYI) is projected to report quarterly earnings at $2.37 per share on revenue of $884.62 million.
